MOEBIUS HANS 4
4 · Athira Pharma, Inc. · Filed Oct 17, 2022
Insider Transaction Report
Form 4
MOEBIUS HANS
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2022-10-13$1.35/sh+7,881$10,639→ 60,836 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-10-13−7,881→ 7,882 totalExercise: $1.35Exp: 2029-08-14→ Common Stock (7,881 underlying)
Footnotes (1)
- [F1]One-fourth of the shares subject to the option vested on June 1, 2020 and one-fourth of the shares subject to the option vest on each year thereafter.